Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
The review said a certain class of drugs had little [...]
GLP-1 Experimentation Is Everywhere, and Science Can’t Keep Up
Millions of Americans are experimenting with the drugs. Science can’t [...]
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been [...]
TrumpRx Is Set to Go Live on Thursday
The government website is meant to connect Americans with drug [...]
The Key to Managing Tariffs: Be Big and Have the President’s Ear
Several large American manufacturers are thriving despite the threat of [...]
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value
The 150-year-old drugmaker is the first company in health care [...]
RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugs
The weight loss medicines are proving to be a test [...]
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
The announcement of the deal signaled an end to the [...]
What Trump’s New Drug Pricing Deal Means for People With Obesity
The president’s agreement with drug companies involves a range of [...]
Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser
Regulators sent about 100 warning letters this week to drug [...]